232 related articles for article (PubMed ID: 25255920)
1. Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.
Vialle-Valentin CE; Serumaga B; Wagner AK; Ross-Degnan D
Health Policy Plan; 2015 Oct; 30(8):1044-52. PubMed ID: 25255920
[TBL] [Abstract][Full Text] [Related]
2. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial.
Rockers PC; Laing RO; Ashigbie PG; Onyango MA; Mukiira CK; Wirtz VJ
Lancet Glob Health; 2019 Apr; 7(4):e492-e502. PubMed ID: 30799142
[TBL] [Abstract][Full Text] [Related]
3. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
4. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
[TBL] [Abstract][Full Text] [Related]
5. Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya.
Wirtz VJ; Turpin K; Laing RO; Mukiira CK; Rockers PC
Trop Med Int Health; 2018 Aug; 23(8):879-885. PubMed ID: 29808960
[TBL] [Abstract][Full Text] [Related]
6. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya.
Rockers PC; Wirtz VJ; Vian T; Onyango MA; Ashigbie PG; Laing R
BMJ Open; 2016 Nov; 6(11):e013386. PubMed ID: 27888177
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda.
Masters SH; Burstein R; DeCenso B; Moore K; Haakenstad A; Ikilezi G; Achan J; Osei I; Garshong B; Kisia C; Njuguna P; Babigumira J; Kumar S; Hanlon M; Gakidou E
PLoS One; 2014; 9(12):e114762. PubMed ID: 25500832
[TBL] [Abstract][Full Text] [Related]
10. Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study.
Kibirige D; Atuhe D; Kampiire L; Kiggundu DS; Donggo P; Nabbaale J; Mwebaze RM; Kalyesubula R; Lumu W
Int J Equity Health; 2017 Aug; 16(1):154. PubMed ID: 28836972
[TBL] [Abstract][Full Text] [Related]
11. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y; Wang Y; Sun X; Li X
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
[TBL] [Abstract][Full Text] [Related]
12. Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines.
Lambojon K; Chang J; Saeed A; Hayat K; Li P; Jiang M; Atif N; Desalegn GK; Khan FU; Fang Y
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708060
[TBL] [Abstract][Full Text] [Related]
13. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
[TBL] [Abstract][Full Text] [Related]
14. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.
Hogerzeil HV; Liberman J; Wirtz VJ; Kishore SP; Selvaraj S; Kiddell-Monroe R; Mwangi-Powell FN; von Schoen-Angerer T;
Lancet; 2013 Feb; 381(9867):680-9. PubMed ID: 23410612
[TBL] [Abstract][Full Text] [Related]
15. The role of government agencies and other actors in influencing access to medicines in three East African countries.
Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
[TBL] [Abstract][Full Text] [Related]
16. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
[TBL] [Abstract][Full Text] [Related]
17. A systematic scoping review of medicine availability and affordability in Africa.
Lane J; Nakambale H; Kadakia A; Dambisya Y; Stergachis A; Odoch WD
BMC Health Serv Res; 2024 Jan; 24(1):91. PubMed ID: 38233851
[TBL] [Abstract][Full Text] [Related]
18. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
19. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
